Business Context and Reporting Period
Company: BioLife Solutions, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 12, 2024
Reporting Period: Third quarter ended September 30, 2024
Context: The filing announces the issuance of a press release containing unaudited financial results and operational highlights for the specified quarter.
Key Financial Metrics
The provided Form 8-K text serves as a notification of the results but does not contain the specific financial data points. The filing states that the unaudited financial results are detailed in the press release furnished as Exhibit 99.1. Consequently, the following metrics are not present in the source text:
- Revenue
- Profit (Net Income/Loss)
- Cash Flow
- Margins
- Debt and Liquidity
Note: The filing text does not provide a clear value for any specific financial metric.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It only references the existence of operational highlights and financial results in the attached press release (Exhibit 99.1).
Guidance, Outlook, and Risks
The provided text does not contain management commentary, forward-looking guidance, specific risk factors, contingencies, or unusual items. These details are referenced as being contained within the press release attached as Exhibit 99.1.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 12, 2024) for actual revenue, profit, and cash flow figures.
- Verify operational highlights and any year-over-year comparisons mentioned in the press release.
- Check for any updated financial guidance or outlook provided in the press release.
- Confirm the unaudited nature of the reported results as stated in the filing.